Drugmaker Merck said Tuesday it is investing $1 billion in a new Delaware plant to expand domestic production as it prepares to deal with President Trump’s tariffs. The new facility will produce ...

Merck is expanding domestic manufacturing with a $895 million investment in its Kansas factory, one of several major projects in the company's strategy to increase U.S. production in the coming ...

Merck is investing $1 billion to build a ... efforts to stimulate economic growth in the U.S., allowing for the domestic production and distribution of medicines and vaccines to patients here ...

PHILADELPHIA (KYW Newsradio) — U.S. drug maker Merck is building a $1 billion facility in Wilmington, Delaware, aimed at increasing domestic production of its cancer drug Keytruda and other ...

April 29 (Reuters) - U.S. drugmaker Merck (MRK.N), opens new tab said on Tuesday it is investing $1 billion in a new Delaware plant to expand domestic production as it prepares to deal with ...

This expansion of our Durham plant is a crucial component of the more than $12 billion Merck has invested toward U.S. capital investment since 2018 focused on expanding domestic manufacturing and ...

Since the advent of the 2017 Tax Cuts and Jobs Act, Merck has allocated more than $12 billion to enhance its domestic manufacturing and research capabilities, with additional planned investments ...

This expansion is a crucial component of the more than $12 billion Merck has invested in the U.S. since 2018. It’s focused on expanding domestic manufacturing and research and development ...

Opening highlights effort to expand U.S. manufacturing through a $1 billion investment DURHAM, N.C., March 11, 2025--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States ...